A Wall Street Analyst Downgraded Salesforce Over AI Product Worries—Here's What That Means

KeyBanc Capital Markets, a respected stock research firm, downgraded Salesforce (CRM) from "Overweight" to "Sector Weight" this week Investing.com. They removed their price target entirely and didn't replace it. The reason: their conversations with Salesforce customers suggest that Agentforce—Salesforce's main artificial intelligence product—isn't catching on the way the company's leaders have promised Yahoo Finance.

For anyone who doesn't follow stock ratings: "Overweight" is analyst shorthand for "this stock should outperform." Downgrading to "Sector Weight" means they now think Salesforce will perform roughly as well as other software companies—not better. That's a meaningful shift.

The timing is awkward for Salesforce. Two days before KeyBanc's downgrade, Salesforce announced it would spend $1 billion in Switzerland to accelerate its AI transformation Salesforce. So investors saw one headline saying the company is betting big on AI, and within 48 hours saw another headline saying customers aren't buying into it yet.

What This Downgrade Is Actually About

KeyBanc didn't downgrade Salesforce because the company missed profit targets or announced disappointing sales numbers. Instead, they called their customers directly—software companies that use Salesforce's products—and asked how well Agentforce is working for them. Their conclusion: there's little sign it's being adopted widely.

This matters because it's not based on Salesforce's official financial reports. It's based on what real customers are telling an analyst when they pick up the phone. That kind of information can sometimes surface problems before they show up in a company's quarterly earnings.

Why Removing the Price Target Is Significant

Analysts almost always give a stock a price target—a number they think the stock should trade at. Removing it entirely is unusual. It suggests KeyBanc wants to separate two different questions: "Is this stock expensive or cheap?" and "Is Salesforce's AI product actually working?" They're focusing on the second question and stepping back from the first.

The broader context here is that Wall Street has already priced in success for Salesforce's AI bet. Investors have bid up the stock's price based on the assumption that Agentforce will drive future growth. If that product isn't gaining traction, that assumption is shaky.

The Tension Between These Two Stories

Salesforce is committing real money to build out Agentforce capabilities. That suggests the company's leaders believe in the product's potential. At the same time, KeyBanc's customer checks say adoption is slow. These don't contradict each other outright—spending $1 billion on infrastructure and future development is different from seeing immediate customer sign-ups—but they do raise a question that investors will be watching for at Salesforce's next earnings call: Will the next quarterly report show Agentforce deals actually picking up, or will the growth story remain a plan on paper while capital gets spent?

What to Watch Next

If you own Salesforce stock or are considering buying it, here's what matters: a firm that investors respect has made a specific claim that can be tested. They say Agentforce adoption isn't accelerating. Salesforce's next quarterly earnings will either support or challenge that claim, because the company typically discloses data on how many customers are buying AI products and what those deals are worth.

Until that report comes out, KeyBanc's downgrade functions less as a "sell this stock now" signal and more as a flag for what to pay attention to. It's a reminder that when a company spends billions on a new product line, that doesn't guarantee customers will buy it, and that conviction from management doesn't always match traction in the market.